Lenvatinib, Belzutifan, Lenvatinib, KEYTRUDA 25 mg/mL concentrate for solution for infusion clinical trials

A randomized phase 2 trial of neoadjuvant pembrolizumab plus belzutifan with or without lenvatinib in patients with localized renal cell carcinoma. The moonlanding trial

This study is looking at new ways to treat kidney cancer before surgery. It's testing a combination of medicines to see if they can shrink tumours. Researchers want to know how well these drugs work and if they help patients feel better with fewer side effects.